Top

Published in:

01-10-2010 | Poster presentation

Current clinical use of the [¹⁸F]FDG PET/CT in breast cancer patients: an audit of local referral patterns

Authors: NJ Laurence, J Searle, J Bristol, ID Lyburn

Published in: Breast Cancer Research | Special Issue 3/2010

Excerpt

[¹⁸F]FDG PET/CT scanning has been shown to be an established, accurate method of detecting many primary and metastatic tumours. However, widespread use of PET/CT scanning in the UK remains generally limited, as it is expensive and restricted to a few tertiary centres. Cheltenham General Hospital receives referrals for patients from across the southwest of England and Wales for [¹⁸F]FDG PET/CT. We looked at the referral patterns of patients with breast cancer to see whether they reflected current indications for [¹⁸F]FDG PET/CT and to see whether the findings impacted on clinical decision-making. …

Title: Current clinical use of the [18F]FDG PET/CT in breast cancer patients: an audit of local referral patterns
Authors: NJ Laurence
J Searle
J Bristol
ID Lyburn
Publication date: 01-10-2010
Publisher: BioMed Central
Published in: Breast Cancer Research / Issue Special Issue 3/2010
Electronic ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr2686

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 3/2010

Preliminary assessment of ShearWave™ elastography features in predicting breast lesion malignancy

Breast density as a predictor of breast cancer risk

An audit to assess the impact of introducing a protocol of bilateral whole breast and axillary ultrasound for assessment of screen-detected cancers

Axillary lymph node fine needle aspiration in breast cancer staging: diagnostic impact of a second 20G spinal needle

Benign solitary breast masses in the prevalent screening round: do they contribute to a high recall rate?

Is digital better?

Keynote webinar | Spotlight on antibody–drug conjugates in cancer